Literature DB >> 20721258

[Establishment nephrolithiasis rat model induced by nanobacteria and analysis of stone formation].

Wei-guo Hu1, Xiao-feng Wang, Tao Xu, Jian-xing Li, Liang Chen, Cheng-fan Yu, Xiao-bo Huang.   

Abstract

OBJECTIVE: To establish nephrolithiasis rat model induced by nanobacteria and to determine the relationship of nanobacteria with nephrolithiasis.
METHODS: Thirty adult male SD rats were randomized into 3 groups (n=10 each): group A, given an intravenous injection of nanobacteria; group B, given an intravenous injection of nanobacteria and taken tetracycline; group C, as normal control. Eight weeks later, all rats were sacrificed and the kidneys were examined for pathology and the 24-h urine N-acetyl-beta-D-aminoglycoside enzyme (NAG) and lactate dehydrogenase (LDH) were detected.
RESULTS: Histopathological studies revealed nanobacteria induced renal tubular crystallization, which was significantly different among the 3 groups (P=0.033). The crystallization was higher in group A than that in group B. The urinary NAG and LDH excretion were significantly different among the 3 groups (P<0.001).
CONCLUSION: Nanobacteria may be involved in the pathogenesis of nephrolithiasis. Tetracycline may inhibit stone formation.

Entities:  

Mesh:

Year:  2010        PMID: 20721258

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  3 in total

1.  Tetracycline attenuates calcifying nanoparticles-induced renal epithelial injury through suppression of inflammation, oxidative stress, and apoptosis in rat models.

Authors:  Yuqing Zhang; Rujian Zhu; Dong Liu; Min Gong; Wei Hu; Qingtong Yi; Jie Zhang
Journal:  Transl Androl Urol       Date:  2019-12

Review 2.  The role of calcifying nanoparticles in biology and medicine.

Authors:  Anton G Kutikhin; Elena B Brusina; Arseniy E Yuzhalin
Journal:  Int J Nanomedicine       Date:  2012-01-19

3.  Calcifying nanoparticles: one face of distinct entities?

Authors:  Anton G Kutikhin; Arseniy E Yuzhalin; Vadim V Borisov; Elena A Velikanova; Alexey V Frolov; Vera M Sakharova; Elena B Brusina; Alexey S Golovkin
Journal:  Front Microbiol       Date:  2014-05-20       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.